Statistics from Altmetric.com
Dry needling of myofascial trigger points (MTPs) effectively reduces pain and disability up to 14 days after treatment—there is little difference in the use of different-sized needles.
Comparison of three needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomised controlled trial
MTPs are small highly sensitive areas in the muscle that are painful to palpation and can cause referred pain—dry needling of MTP's is a commonly used treatment method.
Does the needle diameter of needles used in dry needling of MTPs affect pain during needling and treatment efficacy (pain, disability) after 2 weeks' follow-up?
Subjects: Seventy-seven patients with myofascial pain syndrome (>3 months) (upper- and middle-trapezius muscles).
Experimental procedure: All the subjects were assessed (including neck and upper back pain—Visual Analogue Scale (VAS); Neck Disability Index—NDI; Quality of life from Medical Outcomes Study 36-Item Short-Form Health Survey—SF-36). Subjects were randomised into three groups (n=25 each) receiving trigger point injections on one side of the trapezius with a large- (21), intermediate- (23) or small-gauge (25) needle. Pain during injection was evaluated immediately after injection (VAS). Following the injection, subjects were followed up at 1, 4, 7 and 14 days.
Measures of outcome: Pain (VAS); NDI; quality of life (SF-36); pain intensity during injection (VAS).
▶ Pain: There was a significant decrease in pain (VAS) in all three groups from day 4 post-treatment.
▶ Pain intensity during injection (VAS score) was not significantly different between the groups.
Dry needling of MTPs effectively reduces …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.